New medical imaging technology to aid bone removal in cochlear implant surgery
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Jun-2026 07:16 ET (10-Jun-2026 11:16 GMT/UTC)
The deep, murky pigment known as Prussian blue put the “blue” in traditional blueprints, colored Hokusai’s “Great Wave off Kanagawa” and today is used for industrial purposes from laundry to battery components to poison control. Now, research from the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) has found new uses for the important and inexpensive chemical and new understanding of the mechanisms that make Prussian blue analogs (PBAs) unique. Using insights gleaned from synchrotron anomalous X-ray diffractions through NSF’s ChemMatCARS beamline at the Advanced Photon Source (APS), Argonne National Laboratory, the UChicago PME team used the ion transport properties of the PBA copper hexacyanoferrate to achieve 99.9% lithium purity.
When a plant's immune system is triggered, its growth is stunted. Colorado State University researchers have discovered how to turn on a hormone that allows plants to keep growing as they defend against disease and pests – a breakthrough that could increase crop production.
- uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can be customized as needed - a defining hallmark in the emerging era of personalized medicine. - Offers game-changing potential to impact future biomedical applications, from sealing traumatic wounds to closing surgical incisions. - Bonding strength is comparable to commercially available tissue adhesives.
A research team led by Dr. Ji Chan Park of the Clean Fuel Research Laboratory at the Korea Institute of Energy Research (KIER; President Yi, Chang-Keun) has developed a system that fully automates complex and repetitive catalyst performance evaluation experiments.
Los Angeles, CA –February 23, 2026 – Dr. Vadim Jucaud, Principal Investigator and Assistant Professor at the Terasaki Institute, with Co-Principal Investigator Angeles Baquerizo, MD, PhD, FACS, FAASLD have been awarded an NIH R21 research grant to develop a first-of-its-kind organ-on-a-chip platform to study immune rejection in pig-to-human liver transplantation. The project tackles one of the most pressing challenges in modern transplantation medicine: advancing xenotransplantation toward safe and effective clinical use.